A distinct CAR-T cell phenotype mediates therapeutic response at limited doses
Schayan Yousefian, Maria-Luisa Schubert, Anna Rita Minafra, Patrick Derigs, Sarah Gräßle, Arik Horne, Uta M. Demel, Julian Liebaert, Caroline Röthemeier, Franziska Pupp, Uta E. Höpken, Jan Krönke, Antonia Busse, Ulrich Keller, Anita Schmitt, Daniel Hübschmann, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Simon Haas · 2026
Read A distinct CAR-T cell phenotype mediates therapeutic response at limited doses by Schayan Yousefian, Maria-Luisa Schubert, Anna Rita Minafra, Patrick Derigs, Sarah Gräßle, Arik Horne, Uta M. Demel, Julian Liebaert, Caroline Röthemeier, Franziska Pupp, Uta E. Höpken, Jan Krönke, Antonia Busse, Ulrich Keller, Anita Schmitt, Daniel Hübschmann, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Simon Haas (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13421456.txt.
Description
Schayan Yousefian leads a large team reporting, in a 2026 study, why some patients respond to CAR-T cell therapy even when manufacturing limits force a low dose. CAR-T treatment reprogrammes a patient's own T cells against cancer, and higher doses are normally preferred, yet some low-dose patients enjoy durable responses.
Deep profiling of products from the HD-CAR-1 dose-escalation trial showed that responders' low-dose products were enriched for functional effector and effector memory-like cells, whose absolute count predicted response across doses and targets. Starting material mattered too: supportive myeloid cells in the collected blood fostered good products, while regulatory myeloid states bred dysfunctional ones. The authors propose cell counts as a biomarker for dose decisions.
Catalog record
| CREATOR | Schayan Yousefian, Maria-Luisa Schubert, Anna Rita Minafra, Patrick Derigs, Sarah Gräßle, Arik Horne, Uta M. Demel, Julian Liebaert, Caroline Röthemeier, Franziska Pupp, Uta E. Höpken, Jan Krönke, Antonia Busse, Ulrich Keller, Anita Schmitt, Daniel Hübschmann, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Simon Haas |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 90 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |